Kala Bio KALA
NASDAQ KALA
$0.56 +0.00 (+0.88%)
As of: Sep 10, 2026 · 12:28 PM EDT

Kala Bio (KALA) Raw Materials (2018 - 2019)

Kala Bio's (KALA) quarterly Raw Materials came in at $706000.0 in Q2 2019, up 43.79% quarter-over-quarter from $491000.0 in Q1 2019.

Analysis

Kala Bio (KALA) Raw Materials (2018 - 2019) Analysis & Trends

Kala Bio has disclosed Raw Materials across 2 years of filings, most recently posting $706000.0 for Q2 2019.

  • In Q2 2019, Raw Materials changed N/A year-over-year to $706000.0; the TTM figure through Jun 2019 stood at $706000.0 (changed N/A YoY), while the FY2018 annual figure was $350000.0, changed N/A from the prior year.
  • Raw Materials came in at $706000.0 for Q2 2019 at Kala Bio, up from $491000.0 in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $706000.0 in Q2 2019 to a low of $350000.0 in Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.60 Bn 192.61 Bn 7.24 Bn
2 Gilead Sciences 179.45 Bn 176.27 Bn 6.22 Bn
3 Vertex Pharmaceuticals 131.28 Bn 123.43 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.58 Bn 73.59 Bn 3.93 Bn
5 Argenx Se 60.66 Bn 55.48 Bn 1.37 Bn
6 Moderna 53.76 Bn 48.63 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.39 Bn 30.08 Bn 992.69 Mn
8 Biogen 31.86 Bn 30.58 Bn 1.96 Bn
9 Roivant Sciences 29.09 Bn 29.09 Bn 1.16 Mn
10 Kala Bio 8.59 Mn 8.59 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 706,000.00
Mar 31, 2019 491,000.00
Dec 31, 2018 350,000.00